WE MAKE AQUACULTURE PROGRESS
PHARMAQ voted the best animal health company in Europe in 2015 by AnimalPharm.
Oslo January 27th
"It is with great pleasure and pride that we received the news about this award as the best animal health company in Europe for 2015," Morten Nordstad, President PHARMAQ says. "The fact that our products and innovations have been noticed and ranked to this level gives us motivation to carry on our efforts to support the global aquaculture industry with health products. We are humbled to have won this prize in competition with other skilled and well reputed companies that we highly respect" Morten says.
Animal Pharm is one of the leading online business intelligence companies for the animal health sector. They cover the food producing animal and companion animal sectors. With extensive information on animal health products including antiparasitics, vaccines, pharmaceuticals, feed, feed additives and equipment.
The following is an excerpt of the Animal Pharm story on Pharmaq:
"Best company – Europe”
Norwegian firm Pharmaq was voted the best company in Europe during 2015.In November, Zoetis purchased Pharmaq for a fee that was ten times the value of the aquaculture vaccine firm's annual sales. This highlighted the value placed on assets in the aquaculture space. From 2005 to 2014, Pharmaq's top line posted a compound annual growth rate of 17%.
The deal sent out shockwaves as Zoetis secured the services of one of the leading innovators in "the fastest growing segment of animal health industry".
Established in 1985, the company has around 200 employees and is headquartered in Oslo. However, its reach is global – Pharmaq subsidiaries are in Chile, the UK, Vietnam, Spain, Turkey, Panama and Hong Kong.
The ﬁrm sells a range of AlphaJect injectable vaccines for treatment of furunculosis, vibriosis, coldwater vibriosis, winter sore, infectious pancreatic necrosis, infectious salmon anemia, salmonid rickettsia septicaemia, enteric septicaemia disease and atypical furunculosis. It also sells parasiticides such as AlphaMax, to protect farmed salmon from sea lice.
Pharmaq's dip vaccines protect against vibriosis and pasteurellosis. The company's prescription therapeutics include anesthetics and antimicrobial powders. The company also runs Pharmaq Analytiq as a sister company. This business provides analysis services to the salmon industry, while in September 2015, Pharmaq's diagnostic division became functional."
For more information please contact Morten Nordstad on e-mail email@example.com or phone; +47 23 29 85 10
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
Pharmaq produserer vaksiner til 70 prosent av verdens laks
Europe Fish Vaccine Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025
Pharmaq recibe autorización para comercialización de nueva vacuna
Farmed Salmon is a Core Component of Healthy, Sustainable Diets
Har fått markedsføringstillatelse til ny vaksine - Kyst.no
Global Deltamethrin Market Analysis, Revenue, Share, Size, Developments, Feasibility Check
I denne bygda produserer de vaksiner til 70 prosent av verdens laks
FDA awards grants to help fund MUMS research
How Impact of Covid-19 on Single Drum Friability Testers market Development is Changing Business Needs?
Veterinary Vaccines Market : Facts, Figures and Analytical Insights 2020